Skip to search formSkip to main contentSkip to account menu

besifloxacin

Known as: (+)-7-((3R)-3-Aminohexahydro-1H-Azepin-1-yl)-8-Chloro-1-Cyclopropyl-6-Fluoro-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid, 3-Quinolinecarboxylic Acid, 7-((3R)-3-Aminohexahydro-1H-Azepin-1-yl)-8-Chloro-1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-, 7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 
National Institutes of Health

Related topics

Related topics

14 relations

Broader (3)

AzepinesFluoroquinolonesTopoisomerase II Inhibitors
BESIFLOXACIN HYDROCHLORIDEBacterial InfectionsBesifloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusionMicrobicides

Narrower (3)

BOL-303224-ABesivanceSS734

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Cost comparison of commonly used postoperative topical ophthalmic antibiotics.
Review
2014
Review
2014
BESIFLOXACIN THE FOURTH GENERATION FLUOROQUINOLONE: A REVIEW
Besifloxacin is fourth generation ophthalmic fluoroquinolone of synthetic origin, it was approved by the United States Food and… 
Review
2013
Review
2013
Delayed Epithelial Closure After PRK Associated With Topical Besifloxacin Use
Purpose: To report the observation of prolonged reepithelialization after photorefractive keratectomy (PRK) associated with the… 
2010
2010
Fresh from the biologic pipeline—2009
Human antibodies take center stage, as they pile up in the list of approved biologics in 2009. Cormac Sheridan reports. 
2010
2010
Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Children and Adolescents with Bacterial Conjunctivitis
AbstractBackground: Acute conjunctivitis is the most frequent eye disorder seen by primary care physicians and one that often… 
2010
2010
Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin‐sensitive or methicillin‐resistant Staphylococcus aureus anterior chamber infections
2010
2010
To Market, To Market—2009
2010
2010
Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis.
PURPOSE To study the efficacy of topical administration of gatifloxacin (0.3%), moxifloxacin (0.5%) ophthalmic solutions, and… 
2010
2010
Health supplement associated with intraoperative floppy-iris syndrome.
Review
2009
Review
2009
Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis
Besifloxacin is a new fluoroquinolone anti-infective developed for ophthalmic use. Besifloxacin ophthalmic suspension 0.6… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)